Literature DB >> 15129283

Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.

Maya Saleh1, John P Vaillancourt, Rona K Graham, Matthew Huyck, Srinivasa M Srinivasula, Emad S Alnemri, Martin H Steinberg, Vikki Nolan, Clinton T Baldwin, Richard S Hotchkiss, Timothy G Buchman, Barbara A Zehnbauer, Michael R Hayden, Lindsay A Farrer, Sophie Roy, Donald W Nicholson.   

Abstract

Caspases mediate essential key proteolytic events in inflammatory cascades and the apoptotic cell death pathway. Human caspases functionally segregate into two distinct subfamilies: those involved in cytokine maturation (caspase-1, -4 and -5) and those involved in cellular apoptosis (caspase-2, -3, -6, -7, -8, -9 and -10). Although caspase-12 is phylogenetically related to the cytokine maturation caspases, in mice it has been proposed as a mediator of apoptosis induced by endoplasmic reticulum stress including amyloid-beta cytotoxicity, suggesting that it might contribute to the pathogenesis of Alzheimer's disease. Here we show that a single nucleotide polymorphism in caspase-12 in humans results in the synthesis of either a truncated protein (Csp12-S) or a full-length caspase proenzyme (Csp12-L). The read-through single nucleotide polymorphism encoding Csp12-L is confined to populations of African descent and confers hypo-responsiveness to lipopolysaccharide-stimulated cytokine production in ex vivo whole blood, but has no significant effect on apoptotic sensitivity. In a preliminary study, we find that the frequency of the Csp12-L allele is increased in African American individuals with severe sepsis. Thus, Csp12-L attenuates the inflammatory and innate immune response to endotoxins and in doing so may constitute a risk factor for developing sepsis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15129283     DOI: 10.1038/nature02451

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  122 in total

Review 1.  The protein structures that shape caspase activity, specificity, activation and inhibition.

Authors:  Pablo Fuentes-Prior; Guy S Salvesen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

2.  The inflammasome: in memory of Dr. Jurg Tschopp.

Authors:  M Dagenais; A Skeldon; M Saleh
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

Review 3.  Non-apoptotic functions of apoptosis-regulatory proteins.

Authors:  Lorenzo Galluzzi; Oliver Kepp; Christina Trojel-Hansen; Guido Kroemer
Journal:  EMBO Rep       Date:  2012-04-02       Impact factor: 8.807

Review 4.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 5.  Inhibiting the inflammasome: one domain at a time.

Authors:  Andrea Dorfleutner; Lan Chu; Christian Stehlik
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

6.  Aryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosis.

Authors:  Celine A Beamer; Benjamin P Seaver; David M Shepherd
Journal:  Toxicol Sci       Date:  2012-01-23       Impact factor: 4.849

Review 7.  Mechanisms of cell death in heart disease.

Authors:  Klitos Konstantinidis; Russell S Whelan; Richard N Kitsis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-17       Impact factor: 8.311

Review 8.  Death begets failure in the heart.

Authors:  Roger S-Y Foo; Kartik Mani; Richard N Kitsis
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 9.  Endoplasmic reticulum stress: cell life and death decisions.

Authors:  Chunyan Xu; Beatrice Bailly-Maitre; John C Reed
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

10.  Aberrant TNF secretion by whole blood in healthy subjects with a history of reactive arthritis: time course in adherent and non-adherent cultures.

Authors:  K Anttonen; A Orpana; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.